AGE Annual FCF
-$7.80 M
-$1.86 M-31.34%
31 December 2023
Summary:
As of February 5, 2025, AGE annual free cash flow is -$7.80 million, with the most recent change of -$1.86 million (-31.34%) on December 31, 2023. During the last 3 years, it has risen by +$37.00 thousand (+0.47%).AGE Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AGE Quarterly FCF
-$2.05 M
-$188.00 K-10.09%
31 December 2023
Summary:
As of February 5, 2025, AGE quarterly free cash flow is -$2.05 million, with the most recent change of -$188.00 thousand (-10.09%) on December 31, 2023. Over the past year, it has dropped by -$731.00 thousand (-55.34%).AGE Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AGE TTM FCF
-$7.80 M
-$731.00 K-10.34%
31 December 2023
Summary:
As of February 5, 2025, AGE TTM free cash flow is -$7.80 million, with the most recent change of -$731.00 thousand (-10.34%) on December 31, 2023. Over the past year, it has dropped by -$1.86 million (-31.34%).AGE TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AGE Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -31.3% | -55.3% | -31.3% |
| 3 y3 years | +0.5% | -26.7% | +0.5% |
| 5 y5 years | +21.1% | -0.3% | +27.8% |
AGE Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +31.3% | +66.0% | +178.0% |
AgeX Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$7.80 M(+31.3%) | -$2.05 M(+10.1%) | -$7.80 M(+10.3%) |
| Sept 2023 | - | -$1.86 M(-7.7%) | -$7.07 M(+9.8%) |
| June 2023 | - | -$2.02 M(+8.3%) | -$6.44 M(+4.4%) |
| Mar 2023 | - | -$1.86 M(+41.2%) | -$6.17 M(+3.9%) |
| Dec 2022 | -$5.94 M(-24.4%) | -$1.32 M(+6.9%) | -$5.94 M(-5.2%) |
| Sept 2022 | - | -$1.24 M(-29.2%) | -$6.26 M(-9.4%) |
| June 2022 | - | -$1.75 M(+6.7%) | -$6.91 M(+0.8%) |
| Mar 2022 | - | -$1.64 M(-0.7%) | -$6.86 M(-12.7%) |
| Dec 2021 | -$7.86 M(+0.2%) | -$1.65 M(-12.6%) | -$7.86 M(+0.3%) |
| Sept 2021 | - | -$1.88 M(+11.2%) | -$7.83 M(-0.2%) |
| June 2021 | - | -$1.69 M(-35.6%) | -$7.84 M(-6.6%) |
| Mar 2021 | - | -$2.63 M(+62.3%) | -$8.40 M(+7.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$7.84 M(-27.4%) | -$1.62 M(-14.8%) | -$7.84 M(-12.2%) |
| Sept 2020 | - | -$1.90 M(-15.4%) | -$8.92 M(-7.4%) |
| June 2020 | - | -$2.25 M(+8.7%) | -$9.63 M(-6.0%) |
| Mar 2020 | - | -$2.07 M(-23.6%) | -$10.25 M(-5.1%) |
| Dec 2019 | -$10.80 M(+9.2%) | -$2.71 M(+3.7%) | -$10.80 M(+6.5%) |
| Sept 2019 | - | -$2.61 M(-8.9%) | -$10.14 M(-2.4%) |
| June 2019 | - | -$2.87 M(+9.3%) | -$10.39 M(+7.1%) |
| Mar 2019 | - | -$2.62 M(+28.1%) | -$9.70 M(-1.9%) |
| Dec 2018 | -$9.89 M(+57.3%) | -$2.05 M(-28.5%) | -$9.89 M(+26.1%) |
| Sept 2018 | - | -$2.86 M(+31.8%) | -$7.84 M(+57.5%) |
| June 2018 | - | -$2.17 M(-22.6%) | -$4.98 M(+77.4%) |
| Mar 2018 | - | -$2.81 M | -$2.81 M |
| Dec 2017 | -$6.29 M | - | - |
FAQ
- What is AgeX Therapeutics annual free cash flow?
- What is the all time high annual FCF for AgeX Therapeutics?
- What is AgeX Therapeutics annual FCF year-on-year change?
- What is AgeX Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for AgeX Therapeutics?
- What is AgeX Therapeutics quarterly FCF year-on-year change?
- What is AgeX Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for AgeX Therapeutics?
- What is AgeX Therapeutics TTM FCF year-on-year change?
What is AgeX Therapeutics annual free cash flow?
The current annual FCF of AGE is -$7.80 M
What is the all time high annual FCF for AgeX Therapeutics?
AgeX Therapeutics all-time high annual free cash flow is -$5.94 M
What is AgeX Therapeutics annual FCF year-on-year change?
Over the past year, AGE annual free cash flow has changed by -$1.86 M (-31.34%)
What is AgeX Therapeutics quarterly free cash flow?
The current quarterly FCF of AGE is -$2.05 M
What is the all time high quarterly FCF for AgeX Therapeutics?
AgeX Therapeutics all-time high quarterly free cash flow is -$1.24 M
What is AgeX Therapeutics quarterly FCF year-on-year change?
Over the past year, AGE quarterly free cash flow has changed by -$731.00 K (-55.34%)
What is AgeX Therapeutics TTM free cash flow?
The current TTM FCF of AGE is -$7.80 M
What is the all time high TTM FCF for AgeX Therapeutics?
AgeX Therapeutics all-time high TTM free cash flow is -$2.81 M
What is AgeX Therapeutics TTM FCF year-on-year change?
Over the past year, AGE TTM free cash flow has changed by -$1.86 M (-31.34%)